Marcy l'Etoile - September 9, 2009. Growth in sales:
10.3 % - At constant exchange rates, including business development agreements
6.0 % - At constant exchange rates and scope of consolidation
Growth in operating results before non-recurring items: 16 %
bioMérieux, a world leader in the field of in vitro diagnostics, today released its interim financial report for the six months ended June 30, 2009.
Download
- Filename
- bmx_pr_h1_2009_results.pdf
- Size
- 59 KB
- Format
- application/pdf